-+ 0.00%
-+ 0.00%
-+ 0.00%

Estrella Immunopharma Q1 EPS $(0.05) Beats $(0.18) Estimate

Benzinga·05/18/2026 13:57:11
Listen to the news
Estrella Immunopharma (NASDAQ:ESLA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.18) by 72.22 percent. This is a 44.44 percent increase over losses of $(0.09) per share from the same period last year.